The GLP-1 category is approaching another important inflection point, driven mainly by the launch of oral therapies and the expansion of Medicare access in the U.S., says Terence Flynn, who leads coverage of U.S
Maggi L, Mastromarino P, Macchia S, et al
Pricing and Program Disclaimer All pricing information provided in this publication is approximate and subject to change without notice based on pharmaceutical supply costs, program modifications, changes in medical supervision requirements, and other factors affecting program costs
Therapeutic Potential Due to its high affinity for the IGF-1 receptor and the benefits that activation of this receptor can provide, it has been investigated for its ability to treat: Wounds and Injuries: IGF-1 LR3 supports the regeneration of tendons and nerves after injury, potentially speeding recovery and reducing scar formation